222.87MMarket Cap6.18P/E (TTM)
4.080High3.910Low264.97KVolume4.000Open4.010Pre Close1.06MTurnover0.60%Turnover Ratio1.37P/E (Static)54.63MShares10.66052wk High0.67P/B181.74MFloat Cap3.91052wk Low--Dividend TTM44.54MShs Float31.910Historical High--Div YieldTTM4.24%Amplitude2.460Historical Low4.014Avg Price1Lot Size
Voyager Therapeutics Stock Forum
Very oversold, less than 1% profitable positions, undervalued by all except p/e which is still under market avg.
This was over $10 recently, and earnings were great, except Wall St was scared of recession at the time. I'm guessing once they are satisfied, this will go back up
Dow Jones· 2 mins ago
Voyager Enters into License for Next-Generation Capsid, Bringing Partnered Portfolio of TRACER-Enabled Gene Therapies to 14
Voyager to receive upfront consideration of $15 million and is eligible to receive up to $305 million in potential associated milestone payments and royalties
Voyager Enters into License for Next-Generation Capsid, Bringing Partnered Portfolio of TRACER-Enabled Gene Therapies to 14
Voyager Therapeutics (Nasdaq: VYGR) has announced a new license agreement with Novartis AG (NYSE: NVS) for a novel capsid from Voyager's TRACER™ capsid discovery platform. The capsid will be used in a gene therapy program targeting an undisclosed rare neurologic disease. This agreement expands Voyager's partnered portfolio of TRACER-enabl...
Looks like 6 holds the big buy but we shall see. Don't expect it to get much lower.
No comment yet